Apert syndrome: Evaluation of a treatment algorithm

Plastic and Reconstructive Surgery

Volumn 131, Issue 1, 2013, Pages 132-142

  Fearon, Jeffrey A ^a   Podner, Cindy ^a  

^a The Craniofacial Center Texas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FGFR2 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 2;

ACROCEPHALOSYNDACTYLY; ADOLESCENT; ADULT; ALGORITHM; ARTICLE; CHILD; DECISION SUPPORT SYSTEM; DEVELOPMENTAL DISORDER; EVALUATION; GENETIC MARKER; GENETICS; HUMAN; INFANT; NUCLEOTIDE SEQUENCE; ORTHOPEDIC SURGERY; PATHOLOGY; PHENOTYPE; PRESCHOOL CHILD; REOPERATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ACROCEPHALOSYNDACTYLIA; ADOLESCENT; ADULT; ALGORITHMS; CHILD; CHILD, PRESCHOOL; DECISION SUPPORT TECHNIQUES; DEVELOPMENTAL DISABILITIES; DNA MUTATIONAL ANALYSIS; GENETIC MARKERS; HUMANS; INFANT; ORTHOPEDIC PROCEDURES; PHENOTYPE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872076926     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182729f42     Document Type: Article

References (41)

1. Park WJ, Theda C, Maestri NE, et al. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet. 1995;57:321-328.
2. Wilkie AO, Slaney SF, Oldridge M, et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet. 1995;9:165-172.
3. Hollway GE, Suthers GK, Haan EA, et al. Mutation detection in FGFR2 craniosynostosis syndromes. Hum Genet. 1997;99: 251-255.
4. Ito S, Sekido K, Kanno H, et al. Phenotypic diversity in patients with craniosynostoses unrelated to Apert syndrome: The role of fibroblast growth factor receptor gene mutations. J Neurosurg. 2005;102(Suppl):23-30.
5. Oldridge M, Lunt PW, Zackai EH, et al. Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. Hum Mol Genet. 1997;6:137-143.
6. Moloney DM, Slaney SF, Oldridge M, et al. Exclusive paternal origin of new mutations in Apert syndrome. Nat Genet. 1996; 13:48-53.
7. Yoon SR, Qin J, Glaser RL, et al. The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect. PLoS Genet. 2009;5:e1000558.
8. Glaser RL, Broman KW, Schulman RL, Eskenazi B, Wyrobek AJ, Jabs EW. The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm. Am J Hum Genet. 2003;73:939-947.
9. Allam KA, Wan DC, Khwanngern K, et al. Treatment of apert syndrome: A long-term follow-up study. Plast Reconstr Surg. 2011;127:1601-1611.
10. Marucci DD, Dunaway DJ, Jones BM, Hayward RD. Raised intracranial pressure in Apert syndrome. Plast Reconstr Surg. 2008;122:1162-1168; discussion 1169-1170.
11. Fearon JA. The Le Fort III osteotomy: To distract or not to distract? Plast Reconstr Surg. 2001;107:1091-1103; discussion 1104-1106.
12. Fearon JA. Treatment of the hands and feet in Apert syndrome: An evolution in management. Plast Reconstr Surg. 2003;112:1-12; discussion 13-19.
13. Gillies H, Harrison SH. Operative correction by osteotomy of recessed malar maxillary compound in a case of oxycephaly. Br J Plast Surg. 1950;3:123-127.
14. Murray JE, Swanson LT. Mid-face osteotomy and advancement for craniosynostosis. Plast Reconstr Surg. 1968;41:299- 306.
15. Tessier P. The definitive plastic surgical treatment of the severe facial deformities of craniofacial dysostosis: Crouzon's and Apert's diseases. Plast Reconstr Surg. 1971;48:419-442.
16. Holten IW, Smith AW, Bourne AJ, David DJ. The Apert syndrome hand: Pathologic anatomy and clinical manifestations. Plast Reconstr Surg. 1997;99:1681-1687.
17. Upton J. Apert syndrome: Classification and pathologic anatomy of limb anomalies. Clin Plast Surg. 1991;18:321-355.
18. Cohen MM Jr, Kreiborg S. Cranial size and configuration in the Apert syndrome. J Craniofac Genet Dev Biol. 1994;14:153- 162.
19. Marti'nez-Abadi'as N, Percival C, Aldridge K, et al. Beyond the closed suture in apert syndrome mouse models: Evidence of primary effects of FGFR2 signaling on facial shape at birth. Dev Dyn. 2010;239:3058-3071.
20. Fearon JA, Rhodes J. Pfeiffer syndrome: A treatment evaluation. Plast Reconstr Surg. 2009;123:1560-1569.
21. Cohen MM Jr, Kreiborg S. Unusual cranial aspects of the Apert syndrome. J Craniofac Genet Dev Biol. 1994;14:48-56.
22. Cinalli G, Renier D, Sebag G, Sainte-Rose C, Arnaud E, Pierre-Kahn A. Chronic tonsillar herniation in Crouzon's and Apert's syndromes: The role of premature synostosis of the lambdoid suture. J Neurosurg. 1995;83:575-582.
23. Fearon JA, Swift DM, Bruce DA. New methods for the evaluation and treatment of craniofacial dysostosis-associated cerebellar tonsillar herniation. Plast Reconstr Surg. 2001;108: 1855-1861.
24. Fearon JA, Singh DJ, Beals SP, Yu JC. The diagnosis and treatment of single-sutural synostoses: Are computed tomographic scans necessary? Plast Reconstr Surg. 2007;120:1327- 1331.
25. Slaney SF, Oldridge M, Hurst JA, et al. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am J Hum Genet. 1996;58:923-932.
26. von Gernet S, Golla A, Ehrenfels Y, Schuffenhauer S, Fairley JD. Genotype-phenotype analysis in Apert syndrome suggests opposite effects of the two recurrent mutations on syndactyly and outcome of craniofacial surgery. Clin Genet. 2000;57: 137-139.
27. Lajeunie E, Cameron R, El Ghouzzi V, et al. Clinical variability in patients with Apert's syndrome. J Neurosurg. 1999; 90:443-447.
28. Renier D, Arnaud E, Cinalli G, Sebag G, Zerah M, Marchac D. Prognosis for mental function in Apert's syndrome. J Neurosurg. 1996;85:66-72.
29. Carr MM, Nagy ML, Pizzuto MP, Poje CP, Brodsky LS. Correlation of findings at direct laryngoscopy and bronchoscopy with gastroesophageal reflux disease in children: A prospective study. Arch Otolaryngol Head Neck Surg. 2001;127:369-374.
30. Fearon JA, Ruotolo RA, Kolar JC. Single sutural craniosynostoses: Surgical outcomes and long-term growth. Plast Reconstr Surg. 2009;123:635-642.
31. Fearon JA. Halo distraction of the Le Fort III in syndromic craniosynostosis: A long-term assessment. Plast Reconstr Surg. 2005;115:1524-1536.
32. Shetye PR, Boutros S, Grayson BH, McCarthy JG. Midterm follow-up of midface distraction for syndromic craniosynostosis: A clinical and cephalometric study. Plast Reconstr Surg. 2007;120:1621-1632.
33. Hopper RA, Sandercoe G, Woo A, et al. Computed tomographic analysis of temporal maxillary stability and pterygomaxillary generate formation following pediatric Le Fort IIIdistraction advancement. Plast Reconstr Surg. 2010;126:1665- 1674.
34. Da Costa AC, Savarirayan R, Wrennall JA, et al. Neuropsychological diversity in Apert syndrome: A comparison of cognitive profiles. Ann Plast Surg. 2005;54:450-455.
35. Shipster C, Hearst D, Dockrell JE, Kilby E, Hayward R. Speech and language skills and cognitive functioning in children with Apert syndrome: A pilot study. Int J Lang Commun Disord. 2002;37:325-343.
36. Yacubian-Fernandes A, Palhares A, Giglio A, et al. Apert syndrome: Factors involved in the cognitive development. Arq Neuropsiquiatr. 2005;63:963-968.
37. Starr JR, Kapp-Simon KA, Cloonan YK, et al. Presurgical and postsurgical assessment of the neurodevelopment of infants with single-suture craniosynostosis: Comparison with controls. J Neurosurg. 2007;107(Suppl):103- 110.
38. Mathijssen I, Arnaud E, Lajeunie E, Marchac D, Renier D. Postoperative cognitive outcome for synostotic frontal plagiocephaly. J Neurosurg. 2006;105(Suppl):16-20.
39. McCann ME, Soriano SG. General anesthetics in pediatric anesthesia: Influences on the developing brain. Curr Drug Targets 2012;13:944-951.
40. Vutskits L. Anesthetic-related neurotoxicity and the developing brain: Shall we change practice? Paediatr Drugs 2012; 14:13-21.
41. Wilder RT, Flick RP, Sprung J, et al. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 2009;110:796-804.